NCT04590690 Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
| NCT ID | NCT04590690 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Bariatric Surgery Candidate |
| Study Type | INTERVENTIONAL |
| Enrollment | 28 participants |
| Start Date | 2020-11-01 |
| Primary Completion | 2027-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 28 participants in total. It began in 2020-11-01 with a primary completion date of 2027-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This is a single-center study that aims to better understand how diet and sex affect the risk of kidney stones in people who have had gastric bypass surgery. Subjects will be asked to follow a special (clinic-provided) diet for six days and come to a research clinic for 3 study visits.
Eligibility Criteria
Inclusion Criteria: * Participants without history of stone disease, family history of stone disease * Participants pre-bariatric surgery who are approved and planned for surgery in the Bariatric Surgery Center at University of Chicago Medicine. Exclusion Criteria: * Patients with primary renal diseases or renal impairment (eGFR \< 90) * Patients with known bladder voiding problems * Patients with 25-vitamine D deficiency, as defined by level \< 25ng/mL
Contact & Investigator
Prochaska Megan, MD
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT04590690 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 130 Years, studying Bariatric Surgery Candidate. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04590690 currently recruiting?
Yes, NCT04590690 is actively recruiting participants. Contact the research team at mprocha2@medicine.bsd.uchicago.edu for enrollment information.
Where is the NCT04590690 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT04590690 clinical trial?
NCT04590690 is sponsored by University of Chicago. The principal investigator is Prochaska Megan, MD at University of Chicago. The trial plans to enroll 28 participants.